Published, peer-reviewed research shows a patent-pending, virus-mimicking platform technology developed at Purdue University ...
Research about LENN -- a patent-pending, virus-mimicking platform technology that targets bladder cancer cells with mRNA ...
SAN DIEGO, Feb. 3, 2021 /PRNewswire/ — ViaCyte, Inc., a clinical-stage regenerative medicine company, today announced that the first type 1 diabetes (T1D) patients have been implanted in a Phase 2 ...
A team led by Professor Guosheng Tang from Guangzhou Medical University, Associate Professor Yutao Liu from Tianjin ...
Lipids have become indispensable to modern drug delivery offering a versatile toolkit for the formulation and transport of therapeutic agents. Over the past two decades, the field has experienced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results